Get Prof Nutt’s new book in the Drug Science bookstore. This webinar was recorded during a Drug Science Live Event which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do …
Prof David Nutt and Prof Jan Ramaekers discuss some of the biggest questions in Drug Science in this interview for the European Behavioral Pharmacology Society. They first discuss psychedelics in the treatment of depression, in light of the recent results comparing psilocybin to one of the most commonly prescribed antidepressants. They then address concerns that liberal …
David Nutt – Deep Dive into Alcohol Alcohol is among the most harmful of all recreational drugs, and yet it is the most widely used in the UK. But how much do you really know about what alcohol does to the body and brain? In this video, Professor David Nutt, founder of Drug Science and …
The Roots of Cannabis Policy Change David’s talk will explore the basis of cannabis being a controlled drug with a focus on the political machinations behind the decision to make it illegal in the 1930s. He will then describe the efforts that the charity he set up in 2009 [DrugScience.org.uk] have made to reverse this …
Professor David Nutt explores how psychedelics have been useful for scientists and how their banning has impacted scientific research.
Oxford Psychedelic Society and Oxford Psychology Society hosted a special lecture by Prof. David Nutt followed by an extensive one-hour Q&A session on 14th May 2019. Prof. Nutt discusses how various hallucinogens work on the brain as well as legal barriers preventing research into hallucinogens and how researchers can overcome them.
‘Why It’s Time To Change The Drug Laws – To Improve Treatment and Research’ with Prof. David Nutt. Filmed at Cambridge Skeptics on Tuesday 26th March 2019 at The Cambridge Union Society, Cambridge.
Professor David Nutt presents keynote lecture ‘Psychedelic therapy: A New Paradigm For Mental Health’ at the launch of Mind Medicine Australia
On 1 November 2018 cannabis products changed in legal status from a controlled drug without medical use to a Schedule 2 medicine has significantly implications for psychiatry. Some of these will be good, e.g. the potential to liberate new treatments for disorders such as schizophrenia and PTSD, but others may be bad such as the …
The University of Manchester in association with the British Association for Psychopharmacology were proud to welcome Professor David Nutt to deliver a public lecture on brain science. A phenomenal and fearless speaker, David’s talk covers brain science’s contribution to modern psychiatry, and the potential of groundbreaking new treatments.
Filmed at Breaking Convention: 3rd International Conference on Psychedelic Consciousness, 10-12th July, 2015 Links within video: politicalticker.blogs.cnn.com/2014/01/19/obama-says-marijuana-no-more-dangerous-than-alcohol/ nwph.net/nwpho/publications/alcoholattributablefractions.pdf DrugScience.org.uk @Drug_Science